HCPCS J9041

Injection, bortezomib, 0.1 mg

HCPCS Information
HCPCS Crossover to NDC Codes

HCPCS Information

HCPCS Code: J9041: The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J9041 identifies the type of service or supply used while any of the 21 NDC codes below could be used to specify the exact drug used.
Short Description: Injection, bortezomib, 0.1mg
Long Description: Injection, bortezomib, 0.1 mg
Pricing Indicator: Drugs
Multiple Pricing Indicator: Not applicable as HCPCS priced under one methodology
Coverage Description: Carrier judgment
BETOS Type of Service: Chemotherapy
Medicare Payment Limit: $1.59
Medicare Co-Insurance Percentage: 20.000%
HCPCS Classification: List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0143-9098	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
0409-1700	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Hospira, Inc.	ACTIVE
10019-991	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Baxter Healthcare Corporation	ACTIVE
25021-244	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	ACTIVE
25021-262	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	ACTIVE
31722-303	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Camber Pharmaceuticals, Inc.	ACTIVE
43598-426	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Dr.reddy's Laboratories, Inc.	ACTIVE
50742-484	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Ingenus Pharmaceuticals, Llc	ACTIVE
55150-337	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Eugia Us Llc	ACTIVE
60505-6050	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Apotex Corp	ACTIVE
63020-049	Velcade	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE
63323-821	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
68001-534	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Bluepoint Laboratories	ACTIVE
68001-540	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Bluepoint Laboratories	ACTIVE
68001-541	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Bluepoint Laboratories	ACTIVE
70069-836	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Somerset Therapeutics Llc	ACTIVE
70710-1411	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Zydus Pharmaceuticals Usa Inc.	ACTIVE
70860-225	Bortezomib				Athenex Pharmaceutical Division, Llc.
71288-118	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Meitheal Pharmaceuticals Inc.	ACTIVE
72205-183	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Novadoz Pharmaceuticals Llc	ACTIVE
72603-270	Bortezomib	Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Northstar Rxllc	ACTIVE

Table of Contents

HCPCS Information

HCPCS Crossover to NDC Codes